{"id":"W2557055491","doi":"10.1016/j.ijcard.2016.11.046","title":"Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment","year":2016,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université de Montréal; Montreal Clinical Research Institute","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Ezetimibe; Statin; Internal medicine; Adverse effect; Clinical endpoint; Familial hypercholesterolemia; Apolipoprotein B; Gastroenterology; Clinical trial; Cholesterol","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002860253,0.0001210146,0.0006146507,0.0001398318,0.00000923376,0.0000100779,0.0002854795,0.00008471475,0.000005262199],"category_scores_gemma":[0.00004348454,0.00006163185,0.0001074481,0.00004847025,0.00008311083,0.0001268337,0.00004509769,0.0001163064,0.000002291776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003169893,"about_ca_system_score_gemma":0.0002693394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004340016,"about_ca_topic_score_gemma":0.0001124581,"domain_scores_codex":[0.9986078,0.0001056091,0.0004715435,0.0001854368,0.0004896611,0.0001399409],"domain_scores_gemma":[0.9988191,0.00008422579,0.0002995773,0.0002612279,0.0004584904,0.00007743701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04256763,0.0004185748,0.5853528,0.000002848716,0.00317005,0.0006187569,0.0001919204,0.00008721136,0.001156175,0.00001521815,0.00006286492,0.3663559],"study_design_scores_gemma":[0.07255083,0.0081615,0.9152271,0.0002679156,0.00007177746,0.0002696927,0.00001987614,0.000001326164,0.0003503778,0.00007044028,0.002929797,0.00007943768],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977963,0.0001710502,0.0005702168,0.000547655,0.0002542848,0.000309778,0.0001044983,0.000003182492,0.0002430128],"genre_scores_gemma":[0.998218,0.0004164642,0.0007333772,0.0001422991,0.0004289554,0.000007972134,0.00001844293,0.00001627877,0.00001820823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3662765,"threshold_uncertainty_score":0.2513274,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0295306507424814,"score_gpt":0.2921693733172047,"score_spread":0.2626387225747233,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}